Business Context and Reporting Period
Company: Champions Oncology, Inc. (CSBR)
Filing Type: Form 8-K (Current Report)
Report Date: March 12, 2026
Reporting Period: Third quarter ended January 31, 2026
Context: The Company issued a press release regarding its unaudited financial results for the specified quarter. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release. It does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached Exhibit 99.1 (Press Release) for these figures.
Material Changes
The filing text does not provide details on material changes versus the prior comparable period. Such information is contained within the referenced press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These disclosures are expected to be found in the attached press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 12, 2026) for actual financial results.
- Verify the unaudited nature of the reported figures for the quarter ended January 31, 2026.
- Check for any forward-looking statements or risk factors disclosed in the press release.
- Confirm the trading symbol (CSBR) and exchange (Nasdaq) for current market data.